ARCHIVES

Trial Data: No Benefit In Adding Perifosine to Capecitabine

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012

Organ Systems R01 Grants Doing Okay

February 8, 1985

Duke Comprehensive Cancer Center Wins Core Grant Renewal

September 17, 2010

Synar Bill Provides FDA Regulation Of Tobacco Products

March 4, 1994